Pay in 4 interest-free payments of $7.50 Learn more
Ships within 48 hours · Estimated delivery Sep 10 - Sep 15
is a potent and selective IDH2 inhibitor with potential anticancer activity (IDH2 = Isocitrate dehydrogenase 2)
PubMed PMID: 8826855
InChi: InChI=1S/C31H39N7O2/c1-6-7-23-14-21(4)35-31(40)26(23)18-33-30(39)25-15-24(16-28-27(25)19-34-38(28)20(2)3)22-8-9-32-29(17-22)37-12-10-36(5)11-13-37/h8-9
Sarah Bethune
Berishaj M
ROC-325 - CAS# 1859141-26-6 size:2mg solid is a potent and selectiveROC 325, CAS No. 1859141 26 6, is an autophagy inhibitor. ROC 325 exhibited superior in vitro anticancer effects compared with the existing autophagy inhibitor hydroxychloroquine (HCQ) in 12 different cancer cell lines with diverse genetic backgrounds. ROC 325 antagonized RCC growth and survival in an ATG5 7 dependent manner, induced apoptosis, and exhibited favorable selectivity. Product information CAS Number: 1859141 26 6 Molecular Weight: 503. 06
US$ 60.00
US$ 54.99
US$ 54.99
US$ 54.99
US$ 1245.00